Pavan Patel

Stock Analyst at B of A Securities

(n/a)
# 4,892
Out of 5,064 analysts
1
Total ratings
n/a
Success rate
-18.26%
Average return

Stocks Rated by Pavan Patel

Supernus Pharmaceuticals
Oct 29, 2025
Initiates: Buy
Price Target: $65
Current: $45.32
Upside: +43.42%